Novartis shareholders approve all resolutions proposed by the Board of Directors at the Annual General MeetingGlobeNewsWire • 03/05/24
Novartis presents new data on safety and efficacy of Zolgensma, including maintained and improved motor milestones in older and heavier children with SMAGlobeNewsWire • 03/04/24
This grouping of stocks has actually kept up with the Magnificent Seven, and with a lot less riskMarket Watch • 02/12/24
Novartis to acquire German Biotech MorphoSys for $2.9B, Expanding Cancer Drug PipelineInvestopedia • 02/06/24
Biotech Stock MorphoSys Catapults 56% As Novartis Agrees To Buy It For $2.9 BillionInvestors Business Daily • 02/05/24
Novartis to strengthen oncology pipeline with agreement to acquire MorphoSys AG for EUR 68 per share or an aggregate of EUR 2.7bn in cashGlobeNewsWire • 02/05/24
It's shaping up to be a great quarter for Europe's biggest companies — no thanks to Europe.Market Watch • 02/05/24